Search results

Page results

• New clinical trial aims to improve diagnosis, treatment and rehabilitation of long COVID

  A major new consortium led by UCLH and UCL has been awarded £6.8 million by the National Institute of Health Research to conduct the largest clinical study of long COVID over the next two years.

• Tom Pilston: One Year On (2020)

  In May 2020, UCLH invited acclaimed photographer Tom Pilston to take portraits of staff at the height of the Covid-19 pandemic.

• Antibody levels vary according to vaccine type and previous infection with COVID-19

  Two doses of the Oxford-AstraZeneca COVID-19 vaccine induce lower levels of antibodies that are able to recognise and fight the SARS-CoV-2 Delta variant (B.1.617.2) than against other strains, according to laboratory findings from UCLH and the Francis Crick Institute.

• UCLH researchers first in the world to trial novel cancer treatment

  Researchers at the NIHR UCLH Clinical Research Facility are the first in the world to start a new first-in-human trial investigating a novel treatment, called NVG-111, in patients with Non-Hodgkin lymphoma (NHL) subtypes.

• Trained dogs identify Covid-19 with up to 94% accuracy

  People infected with coronavirus have a distinct odour that can be detected by trained dogs with a high degree of accuracy, according to new research involving UCLH.

• UCLH clinicians elected to Academy of Medical Sciences

  UCLH Director of Research Professor Bryan Williams and Consultant Neuropsychologist at UCLH Professor Lisa Cipolotti have been elected Fellows of the Academy of Medical Sciences in recognition of their exceptional contributions to biomedical and health science.

• Mild Covid-19 infection very unlikely to cause lasting heart damage

  Mild Covid-19 infection is very unlikely to cause lasting damage to the structure or function of the heart, according to a study supported by the NIHR UCLH Biomedical Research Centre and UCLH Charity.

• UCLH to lead data initiative to improve care for myeloma patients

  UCLH is to lead an initiative to improve care for myeloma patients alongside Oxford University Hospitals NHS Foundation Trust (OUH) and University Hospital Southampton NHS Foundation Trust (UHS).

• Alternating vaccines trial to include two additional vaccines

  The Com-Cov trial in which UCLH is a site looking at alternating vaccines has been expanded to include the Moderna and Novavax vaccines.

• Organisations providing further support to anyone affected by cancer or a blood condition

  A directory of UK organisations which provide specialist support to anyone affected by cancer or a blood condition